Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

velagliflozin MeSH Supplementary Concept Data 2025


MeSH Supplementary
velagliflozin
Unique ID
C000628107
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000628107
Entry Term(s)
2-((4-cyclopropylphenyl)methyl)-4-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)benzonitrile
Pharm Action
Hypoglycemic Agents
Registry Numbers
FV2YU8SL0P
Heading Mapped to
*Nitriles
Frequency
3
Note
a sodium-glucose cotransporter 2 (SGLT2) inhibitor for the treatment of diabetes
Source
J Vet Pharmacol Ther. 2018 Apr;41(2):266-273.
Date of Entry
2018/08/28
Revision Date
2018/08/28
velagliflozin Preferred
page delivered in 0.003s